Terpos, E.; Ntanasis-Stathopoulos, I.; Papassotiriou, G.-P.; Kastritis, E.; Margeli, A.; Kanellias, N.; Eleutherakis-Papaiakovou, E.; Migkou, M.; Fotiou, D.; Roussou, M.;
et al. Circulating Soluble Urokinase-Type Plasminogen Activator Receptor Levels Reflect Renal Function in Newly Diagnosed Patients with Multiple Myeloma Treated with Bortezomib-Based Induction. J. Clin. Med. 2020, 9, 3201.
https://doi.org/10.3390/jcm9103201
AMA Style
Terpos E, Ntanasis-Stathopoulos I, Papassotiriou G-P, Kastritis E, Margeli A, Kanellias N, Eleutherakis-Papaiakovou E, Migkou M, Fotiou D, Roussou M,
et al. Circulating Soluble Urokinase-Type Plasminogen Activator Receptor Levels Reflect Renal Function in Newly Diagnosed Patients with Multiple Myeloma Treated with Bortezomib-Based Induction. Journal of Clinical Medicine. 2020; 9(10):3201.
https://doi.org/10.3390/jcm9103201
Chicago/Turabian Style
Terpos, Evangelos, Ioannis Ntanasis-Stathopoulos, Gerasimos-Petros Papassotiriou, Efstathios Kastritis, Alexandra Margeli, Nikolaos Kanellias, Evangelos Eleutherakis-Papaiakovou, Magdalini Migkou, Despina Fotiou, Maria Roussou,
and et al. 2020. "Circulating Soluble Urokinase-Type Plasminogen Activator Receptor Levels Reflect Renal Function in Newly Diagnosed Patients with Multiple Myeloma Treated with Bortezomib-Based Induction" Journal of Clinical Medicine 9, no. 10: 3201.
https://doi.org/10.3390/jcm9103201
APA Style
Terpos, E., Ntanasis-Stathopoulos, I., Papassotiriou, G.-P., Kastritis, E., Margeli, A., Kanellias, N., Eleutherakis-Papaiakovou, E., Migkou, M., Fotiou, D., Roussou, M., Gavriatopoulou, M., Malandrakis, P., Psimenou, E., Papassotiriou, I., & Dimopoulos, M. A.
(2020). Circulating Soluble Urokinase-Type Plasminogen Activator Receptor Levels Reflect Renal Function in Newly Diagnosed Patients with Multiple Myeloma Treated with Bortezomib-Based Induction. Journal of Clinical Medicine, 9(10), 3201.
https://doi.org/10.3390/jcm9103201
